Servier and Teva have been fined for keeping a generic heart medication off the market.
Researchers say it's not just payers supporting the switch, and all ages appear to be brand agnostic.
The regulator says serial filers and time restraints are draining resources and staff.
The Supreme Court split the baby on "pay-for-delay" settlements, allowing them to continue but opening manufacturers that make them up to lawsuits.
The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.